small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (411)
  • Capabilities (79)
  • Experience (105)
  • Insights & News (2,074)
  • Other Results (43)

Professionals 411 results

Michael Kimberly
Michael Kimberly
Partner
  • Washington, DC
Email
+1 202-282-5096
vCard

Partner

  • Washington, DC
Linda Coberly
Linda Coberly
Partner
  • Chicago
Email
+1 312-558-8768
vCard

Partner

  • Chicago
Scott Glauberman
Scott Glauberman
Partner
  • Chicago
Email
+1 312-558-8103
vCard

Partner

  • Chicago
View All Professionals

Capabilities 79 results

Practice Area

Appellate & Critical Motions

Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing....Read more

Practice Area

Litigation/Trials

Trial skills matter—even in a world where few disputes ever see the inside of a courtroom. Winston has built a reputation as a trial lawyers’ firm, featuring seasoned litigators who leverage extensive courtroom experience to meet our clients’ business and legal objectives. Our long history of taking cases to trial—and winning—provides our clients with tremendous settlement leverage with their adversaries, as well as a substantial likelihood of a favorable resolution if, and when, they go to trial....Read more

Practice Area

Corporate Governance

Our attorneys have extensive experience counseling U.S. and multinational public companies across a range of industries in all aspects of corporate governance, securities, and compliance matters. We advise public companies, boards of directors and their committees, and senior executives on the corporate governance and compliance matters that public companies and their leadership confront—from board structuring and succession planning to shareholder activism and SEC regulation. Drawing on our experience as seasoned counselors, we keep clients abreast of evolving trends and best practices to proactively manage any governance or compliance issues. We have assembled one of the most experienced teams of any law firm in the country that’s counseling public companies....Read more

Experience 105 results

Experience

|

November 19, 2025

Blockfusion Enters into Business Combination with Blue Acquisition Corp.

Winston & Strawn LLP represents Blockfusion, the owner-operator of a strategically located, clean-energy-powered data center, in its announced business combination with Blue Acquisition Corp., a publicly traded special purpose acquisition company. The transaction attributes a pre-money equity value of approximately USD 450 million to Blockfusion and would result in Blockfusion becoming a publicly traded company upon listing....Read more

Experience

|

October 1, 2025

AA Mission Acquisition Corp. II - Initial Public Offering

Winston & Strawn LLP represented AA Mission Acquisition Corp. II, a blank check company, in the recent closing of its $100 million Initial Public Offering (IPO). The offering consisted of 10,000,000 units priced at $10.00 per unit, before deducting underwriting discounts and estimated offering expenses. The units began trading on the New York Stock Exchange (NYSE) under the ticker symbol “YCY.U” on October 1, 2025....Read more

Experience

|

September 9, 2025

Greenland Exploration Limited enters business combination with Pelican Acquisition Corporation and March GL Company

Winston & Strawn LLP represented Greenland Exploration Limited in a landmark business combination with Pelican Acquisition Corporation (NASDAQ: PELI) and March GL Company. The transaction, structured as a merger agreement, will result in the formation of Greenland Energy Company, expected to be publicly listed on NASDAQ under the ticker symbol “GLND.” Winston advised Greenland Exploration on all aspects of the deal, including regulatory strategy, corporate structuring, and negotiation of the merger terms....Read more
View All Experience

Insights & News 2,074 results

Seminar/CLE

|

January 29, 2026

Winston Hosts 2026 Financial Services Symposium in Charlotte

 

 

Investigations, Enforcement, & Compliance Alerts

|

January 15, 2026

|

2 Min Read

White House Unveils Landmark Initiative: New DOJ Fraud Division to Be Directly Overseen by Administration

In a move that would mark a significant departure from longstanding practice separating Department of Justice operations from direct White House control, the White House announced on January 8, 2026, a plan to create and directly supervise a new Department of Justice (DOJ) division for national fraud enforcement. The division would be led by a Senate-confirmed assistant attorney general (AAG). According to Vice President Vance, the new AAG will have “nationwide jurisdiction over the issue of fraud” and will be supervised by President Trump and Vice President Vance, rather than by DOJ leadership.  

Recognitions

|

January 14, 2026

|

1 Min Read

Winston Attorneys Inducted Into the 2026 Lawdragon Hall of Fame

Winston & Strawn partners Jonathan Birenbaum, Billie Ellis, and Laura Petroff were named among the 2026 class of the Lawdragon Hall of Fame Inductees. The honor recognizes outstanding lawyers who have made remarkable and lasting contributions to the legal profession. ...Read more
View All Insights & News

Other Results 43 results

Law Glossary

Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?

The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here....Read more

Law Glossary

What Is the Purple Book?

Maintained by the FDA, the Purple Book lists biologic products and biosimilar products that FDA has licensed under the Public Health Service Act. In addition, the Purple Book identifies the date each biologic obtained FDA licensure and indicates whether any biosimilar is interchangeable with its associated reference product....Read more

Site Content

What Is Blockchain?

Blockchain is a technological system in which a digital list of records stored across a network. The network is a shared database comprised of a large number of computers. Blockchain is the primary technology for cryptocurrencies....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising